Chemistry:Diosuxentan

From HandWiki

Diosuxentan is an investigational new drug that is being developed by Biocity Biopharmaceutics for the treatment of diabetic nephropathy. It is an endothelin A receptor antagonist.[1][2]

References

  1. ↑ "Diosuxentan". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800072195. 
  2. ↑ "Next-generation therapeutics and renaissance of legacy drugs targeting the endothelin system". Canadian Journal of Physiology and Pharmacology 104: 1–16. January 2026. doi:10.1139/cjpp-2026-0068. PMID 42378327. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Diosuxentan&oldid=4584044"